Lee Ainslie Exact Sciences Corp Transaction History

Maverick Capital LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$93.66 - $139.27 $20,979 - $31,196	-224 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$116.57 - $155.01 $26,111 - $34,722	224 New	224 $30,000
Q4 2020 Feb 16, 2021	SELL	$99.61 - $142.12 $228,704 - $326,307	-2,296 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$72.92 - $102.01 $167,424 - $234,214	2,296 New	2,296 $234,000
Q4 2019 Feb 14, 2020	SELL	$77.66 - $99.74 $781,259 - $1 Million	-10,060 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$90.37 - $122.49 $909,122 - $1.23 Million	10,060 New	10,060 $909,000

676

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.1B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.